Lysosomal compartment and autophagy degradation machinery

The lysosomal compartment and autophagy degradation machinery constitute a fundamental cellular system for the degradation and recycling of intracellular components, including long-lived proteins and damaged organelles (Mizushima et al., 2008). This process, primarily macroautophagy, involves the sequestration of cytoplasmic material into double-membrane vesicles called autophagosomes, which then fuse with lysosomes to form autolysosomes where acidic hydrolases degrade the cargo (Klionsky et al., 2021). This machinery is essential for maintaining cellular proteostasis and nutrient balance, particularly during periods of starvation or stress. Malfunction of this system is a hallmark of various diseases; for instance, impaired lysosomal clearance leads to the accumulation of toxic protein aggregates in neurodegenerative disorders like Parkinson's and Alzheimer's (Nixon, 2013). In oncology, the pathway exhibits a dual role, acting as a tumor suppressor in early stages but facilitating survival and drug resistance in established tumors (White, 2012). Therapeutic strategies include the use of lysosomotropic agents like hydroxychloroquine to inhibit degradation or mTOR inhibitors like rapamycin to stimulate the pathway. However, the broad physiological importance of these processes necessitates careful consideration of systemic safety and potential off-target effects (Levine & Kroemer, 2019).

Other names

Autophagy-lysosome pathwayLysosomal-autophagy systemMacroautophagy machineryLysosomal degradation pathway

Inhibition of lysosomal acidification, inhibition of autophagosome-lysosome fusion, mTOR signaling inhibition (autophagy induction), and inhibition of class III PI3K (VPS34).